1st customized CRISPR gene-editing treatment
Post# of 55
(Total Views: 58)
Posted On: 05/19/2025 9:48:42 AM
1st customized CRISPR gene-editing treatment
World's First! In a historic medical breakthrough, a child diagnosed with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy by a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine.
Potential Impact on Bionano’s Saphyr System
Complementary Technologies – CRISPR focuses on gene editing, while optical genome mapping (OGM) with Saphyr excels at detecting structural variants (SVs). The two technologies could work together to improve genetic diagnostics and personalized treatments.
Advancing Rare Disease Research – CHOP’s CRISPR breakthrough demonstrates the power of targeted genetic corrections, which could lead to more demand for high-resolution genome mapping. an area where Saphyr is highly effective.
Regulatory & Clinical Adoption – The success of CRISPR-based therapies could accelerate FDA approvals for advanced genomic tools, potentially benefiting OGM adoption in clinical settings.
Competitive Landscape – As CRISPR gains traction, institutions may look for complementary technologies like OGM to validate genetic modifications and ensure comprehensive genomic analysis.
World's First! In a historic medical breakthrough, a child diagnosed with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy by a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine.
Potential Impact on Bionano’s Saphyr System
Complementary Technologies – CRISPR focuses on gene editing, while optical genome mapping (OGM) with Saphyr excels at detecting structural variants (SVs). The two technologies could work together to improve genetic diagnostics and personalized treatments.
Advancing Rare Disease Research – CHOP’s CRISPR breakthrough demonstrates the power of targeted genetic corrections, which could lead to more demand for high-resolution genome mapping. an area where Saphyr is highly effective.
Regulatory & Clinical Adoption – The success of CRISPR-based therapies could accelerate FDA approvals for advanced genomic tools, potentially benefiting OGM adoption in clinical settings.
Competitive Landscape – As CRISPR gains traction, institutions may look for complementary technologies like OGM to validate genetic modifications and ensure comprehensive genomic analysis.
(0)
(0)Bionano Genomics Inc. (BNGO) Stock Research Links
Scroll down for more posts ▼